Boston Scientific Corp. (BSX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1151400,
    "name": "Boston Scientific Corp.",
    "stock_name": "Boston Scientific Corp.",
    "full_name": "Boston Scientific Corp.",
    "name_url": "stocks-analysis/boston-scientific-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "97.72",
    "chg": -0.85,
    "chgp": "-0.86%",
    "dir": -1,
    "prev_price": "98.57",
    "mcapval": "188,708.79",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 3270,
    "indexname": "S&P 500",
    "isin": "US1011371077",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "18.82 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/boston-scientific-corp-1151400-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/boston-scientific-hits-day-high-with-395-surge-outperforming-sp-500-3641309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BostonScientifi_priceRelatedfactors_3641309.png",
        "date": "2025-10-23 17:30:48",
        "description": "Boston Scientific Corp. has shown significant growth, with a notable intraday high and strong weekly and monthly performance. The company has outperformed the S&P 500 in annual and year-to-date gains. Key financial metrics indicate robust sales growth and high institutional investor support, reflecting its resilience in the industry."
      },
      {
        "title": "Boston Scientific Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/boston-scientific-forms-death-cross-signaling-potential-bearish-trend-ahead-3640340",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BostonScientifi_dealthcross_3640340.png",
        "date": "2025-10-20 15:09:27",
        "description": "Boston Scientific Corp. has recently encountered a Death Cross, indicating a potential shift in market sentiment. While technical indicators suggest a bearish trend, the stock has shown resilience with a one-year performance slightly outperforming the S&P 500. Mixed signals from various indicators suggest a complex market position."
      },
      {
        "title": "Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/boston-scientific-corp-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-decline-3600893",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BostonScientifi_technicaldot_3600893.png",
        "date": "2025-10-07 19:26:15",
        "description": "Boston Scientific Corp. has recently revised its evaluation amid fluctuating market conditions. The stock is priced at $96.70, reflecting volatility over the past year. Performance comparisons with the S&P 500 show mixed results, with notable outperformance over three years but recent underperformance in the last month."
      },
      {
        "title": "Is Boston Scientific Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-boston-scientific-corp-technically-bullish-or-bearish-3593427",
        "imagepath": "",
        "date": "2025-10-06 11:57:37",
        "description": "As of 3 October 2025, the technical trend for Boston Scientific Corp. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD, KST, and Dow Theory indicators all indicating bearish momentum. The Bollinger Bands show a bearish signal on the weekly timeframe, while daily moving averages are mildly bullish. The stock has underperformed the S&P 500 over the past week and month, with returns of -0.88% and -9.50% compared to the benchmark's gains of 1.09% and 4.15%, respectively. However, it has outperformed the S&P 500 over longer periods, including a 144.03% return over three years...."
      },
      {
        "title": "Is Boston Scientific Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-boston-scientific-corp-technically-bullish-or-bearish-3591499",
        "imagepath": "",
        "date": "2025-10-05 11:42:44",
        "description": "As of 3 October 2025, the technical trend for Boston Scientific Corp. has changed from sideways to mildly bearish. The MACD indicates a mildly bearish stance on both weekly and monthly time frames, while the KST and Dow Theory also reflect a mildly bearish outlook. The Bollinger Bands show a bearish signal on the weekly chart but a mildly bullish signal on the monthly chart. The daily moving averages are mildly bullish, providing some counterbalance. \n\nIn terms of performance, Boston Scientific has underperformed the S&P 500 over the past week and month, with returns of -0.88% and -9.50% compared to the S&P 500's gains of 1.09% and 4.15%, respectively. However, it has outperformed the benchmark over the longer term, with a 3-year return of 144.03% versus the S&P 500's 82.57%. Overall, the current technical stance is mildly bearish...."
      },
      {
        "title": "Is Boston Scientific Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-boston-scientific-corp-technically-bullish-or-bearish-3545134",
        "imagepath": "",
        "date": "2025-09-20 19:04:27",
        "description": "As of 10 September 2025, the technical trend for Boston Scientific Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly and monthly MACD, KST, and OBV show a mildly bearish trend. Bollinger Bands present a mixed signal with weekly bearishness and monthly mild bullishness. The stock has underperformed the S&P 500 over the past week and month, but it has outperformed over the year and longer periods, with a 1Y return of 18.97% compared to the S&P 500's 17.14%...."
      },
      {
        "title": "Is Boston Scientific Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-boston-scientific-corp-overvalued-or-undervalued-3541856",
        "imagepath": "",
        "date": "2025-09-20 17:38:07",
        "description": "As of 23 July 2025, Boston Scientific Corp. has moved from very expensive to attractive, indicating a significant shift in its valuation perspective. The company appears to be undervalued, especially when considering its P/E ratio of 86, which is notably higher than the peer average P/E of 73.71, and an EV to EBITDA ratio of 44.86 compared to the peer average of 45.38. Additionally, the PEG ratio stands at 6.37, suggesting that the stock may not be priced favorably relative to its earnings growth potential.\n\nIn terms of peer comparison, McKesson Corp. has a P/E of 57.25 and Cencora, Inc. has a P/E of 40.09, both of which indicate that Boston Scientific's valuation is higher, yet it is classified as attractive due to its growth prospects. Despite recent underperformance with a 1-week return of -5.86% compared to the S&P 500's 1.05%, the company has shown resilience with a 3-year return of 135.56%, significan..."
      }
    ],
    "total": 12,
    "sid": "1151400",
    "stock_news_url": "https://www.marketsmojo.com/news/boston-scientific-corp-1151400"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500

2025-10-23 17:30:48

Boston Scientific Corp. has shown significant growth, with a notable intraday high and strong weekly and monthly performance. The company has outperformed the S&P 500 in annual and year-to-date gains. Key financial metrics indicate robust sales growth and high institutional investor support, reflecting its resilience in the industry.

Boston Scientific Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-10-20 15:09:27

Boston Scientific Corp. has recently encountered a Death Cross, indicating a potential shift in market sentiment. While technical indicators suggest a bearish trend, the stock has shown resilience with a one-year performance slightly outperforming the S&P 500. Mixed signals from various indicators suggest a complex market position.

Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability

2025-10-07 19:26:15

Boston Scientific Corp. has recently revised its evaluation amid fluctuating market conditions. The stock is priced at $96.70, reflecting volatility over the past year. Performance comparisons with the S&P 500 show mixed results, with notable outperformance over three years but recent underperformance in the last month.

Is Boston Scientific Corp. technically bullish or bearish?

2025-10-06 11:57:37

As of 3 October 2025, the technical trend for Boston Scientific Corp. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD, KST, and Dow Theory indicators all indicating bearish momentum. The Bollinger Bands show a bearish signal on the weekly timeframe, while daily moving averages are mildly bullish. The stock has underperformed the S&P 500 over the past week and month, with returns of -0.88% and -9.50% compared to the benchmark's gains of 1.09% and 4.15%, respectively. However, it has outperformed the S&P 500 over longer periods, including a 144.03% return over three years....

Is Boston Scientific Corp. technically bullish or bearish?

2025-10-05 11:42:44

As of 3 October 2025, the technical trend for Boston Scientific Corp. has changed from sideways to mildly bearish. The MACD indicates a mildly bearish stance on both weekly and monthly time frames, while the KST and Dow Theory also reflect a mildly bearish outlook. The Bollinger Bands show a bearish signal on the weekly chart but a mildly bullish signal on the monthly chart. The daily moving averages are mildly bullish, providing some counterbalance. In terms of performance, Boston Scientific has underperformed the S&P 500 over the past week and month, with returns of -0.88% and -9.50% compared to the S&P 500's gains of 1.09% and 4.15%, respectively. However, it has outperformed the benchmark over the longer term, with a 3-year return of 144.03% versus the S&P 500's 82.57%. Overall, the current technical stance is mildly bearish....

Is Boston Scientific Corp. technically bullish or bearish?

2025-09-20 19:04:27

As of 10 September 2025, the technical trend for Boston Scientific Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly and monthly MACD, KST, and OBV show a mildly bearish trend. Bollinger Bands present a mixed signal with weekly bearishness and monthly mild bullishness. The stock has underperformed the S&P 500 over the past week and month, but it has outperformed over the year and longer periods, with a 1Y return of 18.97% compared to the S&P 500's 17.14%....

Is Boston Scientific Corp. overvalued or undervalued?

2025-09-20 17:38:07

As of 23 July 2025, Boston Scientific Corp. has moved from very expensive to attractive, indicating a significant shift in its valuation perspective. The company appears to be undervalued, especially when considering its P/E ratio of 86, which is notably higher than the peer average P/E of 73.71, and an EV to EBITDA ratio of 44.86 compared to the peer average of 45.38. Additionally, the PEG ratio stands at 6.37, suggesting that the stock may not be priced favorably relative to its earnings growth potential. In terms of peer comparison, McKesson Corp. has a P/E of 57.25 and Cencora, Inc. has a P/E of 40.09, both of which indicate that Boston Scientific's valuation is higher, yet it is classified as attractive due to its growth prospects. Despite recent underperformance with a 1-week return of -5.86% compared to the S&P 500's 1.05%, the company has shown resilience with a 3-year return of 135.56%, significan...

View All News